Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...
Tumor agnostic efficacy and safety of erdafitinib (erda) in patients (pts) with advanced solid tumors with prespecified FGFR alterations (FGFRalt): RAGNAR primary analysis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results